These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 8452114)

  • 61. Anti-nausea effects and pharmacokinetics of ondansetron, maropitant and metoclopramide in a low-dose cisplatin model of nausea and vomiting in the dog: a blinded crossover study.
    Kenward H; Elliott J; Lee T; Pelligand L
    BMC Vet Res; 2017 Aug; 13(1):244. PubMed ID: 28814338
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Randomized, double-blind, cross-over study comparing prochlorperazine and lorazepam with high-dose metoclopramide and lorazepam for the control of emesis in patients receiving cytotoxic chemotherapy.
    Bishop JF; Wolf M; Matthews JP; Scott K; Ackland S; Yuen K; Morton C; Hillcoat BL; Cooper IA
    Cancer Treat Rep; 1987 Nov; 71(11):1007-11. PubMed ID: 3315193
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Immediate termination of intractable vomiting induced by cisplatin combination chemotherapy using an intensive five-drug antiemetic regimen.
    Plezia PM; Alberts DS; Kessler J; Aapro MS; Graham V; Surwit EA
    Cancer Treat Rep; 1984 Dec; 68(12):1493-5. PubMed ID: 6542448
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Efficacy & tolerability of ondansetron compared to metoclopramide in dose dependent cisplatin-induced delayed emesis.
    Bhatia A; Tripathi KD; Sharma M
    Indian J Med Res; 2004 Sep; 120(3):183-93. PubMed ID: 15489556
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Control of acute cisplatin-induced emesis over repeat courses of chemotherapy. Italian Group for Antiemetic Research.
    Roila F
    Oncology; 1996 Jun; 53 Suppl 1():65-72. PubMed ID: 8692554
    [TBL] [Abstract][Full Text] [Related]  

  • 66. A randomized, multicenter study comparing the efficacy and tolerability of tropisetron, a new 5-HT3 receptor antagonist, with a metoclopramide-containing antiemetic cocktail in the prevention of cisplatin-induced emesis.
    Sorbe BG; Högberg T; Glimelius B; Schmidt M; Wernstedt L; Hansen O; Sörensen BT; Räisänen I; van Oosterom AT; de Bruijn KM
    Cancer; 1994 Jan; 73(2):445-54. PubMed ID: 8293412
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Ondansetron plus dexamethasone versus metoclopramide plus dexamethasone plus diphenhydramine in cisplatin-treated patients with ovarian cancer. Italian Group for Antiemetic Research.
    Support Care Cancer; 1994 May; 2(3):167-70. PubMed ID: 8032702
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Prochlorperazine and transdermal scopolamine added to a metoclopramide antiemetic regimen. A controlled comparison.
    Malone JM; Christensen CW; Yashinsky D; Malviya VK; Deppe G
    J Reprod Med; 1990 Oct; 35(10):932-4. PubMed ID: 2246759
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Optimal control of acute cisplatin-induced emesis.
    Verweij J; de Wit R; de Mulder PH
    Oncology; 1996 Jun; 53 Suppl 1():56-64. PubMed ID: 8692553
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The role of metoclopramide in acute and delayed chemotherapy induced emesis: a randomised double blind trial.
    O'Brien ME; Cullen MH; Woodroffe C; Kelly K; Burman C; Palmer K; Stuart NS; Blackledge GR; Sharpe J
    Br J Cancer; 1989 Nov; 60(5):759-63. PubMed ID: 2679853
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Continuous infusion versus intermittent short infusion of metoclopramide for cisplatin-induced acute emesis.
    Saito H; Shimokata K; Yamori S; Kajita M; Niimi T
    Am J Clin Oncol; 1994 Oct; 17(5):422-6. PubMed ID: 8092115
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Ondansetron compared with high-dose metoclopramide in prophylaxis of acute and delayed cisplatin-induced nausea and vomiting. A multicenter, randomized, double-blind, crossover study.
    De Mulder PH; Seynaeve C; Vermorken JB; van Liessum PA; Mols-Jevdevic S; Allman EL; Beranek P; Verweij J
    Ann Intern Med; 1990 Dec; 113(11):834-40. PubMed ID: 2146911
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Cinnarizine for prevention of nausea and vomiting during platin chemotherapy.
    Wilder-Smith CH; Schimke J; Osterwalder B; Senn HJ
    Acta Oncol; 1991; 30(6):731-4. PubMed ID: 1958394
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Factors that influence the antiemetic activity of metoclopramide to cisplatin based chemotherapy.
    Tsavaris N; Mylonakis N; Bacoyiannis C; Kosmas C; Kalergis G; Iakovidis V; Tzaninis D; Kosmidis P
    Oncol Rep; 1998; 5(5):1147-55. PubMed ID: 9683826
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The influence of dexamethasone in the decrease of chemotherapy-induced nausea and vomiting.
    Sarcev T; Secen N; Povazan Dj; Sabo A; Popovic J; Bursac D; Kakas M; Zaric B; Milovancev A
    J BUON; 2007; 12(2):245-52. PubMed ID: 17600880
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Randomized crossover antiemetic study in cisplatin-treated patients. Comparison between high-dose i.v. metoclopramide and high-dose i.v. dexamethasone.
    Frustaci S; Grattoni E; Tumolo S; Crivellari D; Figoli F; Galligioni E; Veronesi A; Tirelli U; Grigoletto E
    Cancer Chemother Pharmacol; 1986; 17(1):75-9. PubMed ID: 3698180
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Protection from nausea and vomiting in cisplatin-treated patients: high-dose metoclopramide combined with methylprednisolone versus metoclopramide combined with dexamethasone and diphenhydramine: a study of the Italian Oncology Group for Clinical Research.
    Roila F; Tonato M; Basurto C; Picciafuoco M; Bracarda S; Donati D; Malacarne P; Monici L; Di Costanzo F; Patoia L
    J Clin Oncol; 1989 Nov; 7(11):1693-700. PubMed ID: 2681556
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Effective control of cisplatin induced emesis by combination drug regimen.
    Misra R; Agarwal N
    Indian J Cancer; 1994 Mar; 31(1):19-22. PubMed ID: 8063331
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Antiemetic efficacy of high-dose metoclopramide, diphenhydramine, methylprednisolone and diazepam on chemotherapy-induced emesis in gynecological malignancy].
    Hayashi Y; Iwasaka T; Hachisuga T; Fukuda K; Tanaka T; Matsuo N; Sugimori H
    Nihon Sanka Fujinka Gakkai Zasshi; 1988 Jul; 40(7):875-9. PubMed ID: 3418195
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Incidence, course, and severity of delayed nausea and vomiting following the administration of high-dose cisplatin.
    Kris MG; Gralla RJ; Clark RA; Tyson LB; O'Connell JP; Wertheim MS; Kelsen DP
    J Clin Oncol; 1985 Oct; 3(10):1379-84. PubMed ID: 4045527
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.